Low-cost treatments for heart attack underused in blacks, women and the poor

August 06, 2000

DALLAS, Aug. 8 -- Blacks, women and poor people who have a heart attack are less likely to receive proven, inexpensive treatments such as aspirin or beta-blocker therapy, according to an article in today's Circulation: Journal of the American Heart Association.

"Aspirin and beta-blockers are very, very cheap," says Kevin A. Schulman, M.D., an associate professor of Medicine at Duke University Medical Center in Durham, N.C., and co-author of the study conducted at Georgetown University Medical Center. "Both have been shown to reduce death from heart attacks and are considered some of the best medications doctors have available."

Schulman says treatment discrepancies were strongest among blacks and the poor.

"We found that race influences treatment recommendations for individual patients, and we saw that poorer individuals seem to experience differences in care, even when the treatment is covered by Medicare," he says.

"The differences in treatment that we found are not huge, but they are significant," says co-author Bernard J. Gersh, M.B., D. Phil., professor of medicine at the Mayo Foundation and a consultant in the division of cardiovascular diseases at the Mayo Clinic.

"Clearly, physicians don't willingly treat patients differently just because they're poor, black, or women," says Gersh. "There are many factors at work. The important thing is to find out what they are and how to correct them."

Researchers evaluated four medical therapies recommended for the treatment of heart attack ­ two given on admission, and two prescribed on discharge ­ among 169,079 Medicare beneficiaries who were hospitalized for a heart attack between 1994 and 1996. The research team evaluated whether the patients were given aspirin or clot-busting drugs upon admission to the hospital, then whether they were prescribed aspirin and/or beta-blockers when they were released from the hospital.

In the first few hours after a heart attack, aspirin and clot-busting drugs have been proven to improve a person's chance of survival and minimize heart damage. Once a heart attack survivor is released from the hospital, aspirin and beta-blockers help prevent recurrent heart attacks.

Researchers found that blacks were 16 percent less likely than whites to get clot-busting drugs and 3 percent less likely to get aspirin upon admission to the hospital. Blacks also were 6 percent less likely to leave the hospital with prescriptions for beta-blockers. Women were 2 percent less likely than men to get aspirin on arrival or departure, but received the other drugs at the same rate as men. Individuals from low-income areas were 2 to 3 percent less likely to get every treatment than people who were not poor. Among all categories of patients, those in the study who did receive the therapies tended to be younger and to have less severe disease.

"Although 2 or 3 percent doesn't sound very high, heart disease is one of the most prevalent conditions in the country," Schulman says. "Even a small percentage difference in treatment methods can mean large numbers of patients missing out on these therapies."

Schulman says there have been some explanations for racial differences in the treatment of heart attacks, but they don't seem to add up. "Although the prevalence and severity of heart disease may differ by race, there is no research to suggest that recommended treatments will be more or less effective in different races."

Schulman speculates that part of the issue with women may be that they haven't been included in many of the major clinical trials in cardiology. As a result, he says, the amount of information to base medical decisions on is lacking for women.

As for the lower income individuals, Schulman says decreased use of these therapies is hard to explain. "While deductibles or copayments might account for variation in the use of high-cost therapies, it is unlikely that they would influence the use of aspirin or beta-blockers, which are relatively inexpensive," he says. Independent of a patient's race and gender, the researchers found that poorer patients were less likely to receive any of the four treatments discussed in the study.

"On the physicians' side," Schulman says, "we need to understand how we train physicians to deal with patients who differ from themselves either by race, gender or socioeconomic status, as well as how to communicate more effectively."
-end-
Co-authors of the study include Saif S. Rathore, A.B.; Alan K. Berger, M.D.; Kevin P. Weinfurt, Ph.D.; Manning Feinleib, M.D., Dr.P.H.; and William J. Oetgen, M.D., M.B.A.

NR00-1162 (Circ/Schulman)

Media advisory: Dr. Schulman can be reached by phone at 919-668-8101; by fax at 919-668-7124; or by Email at schulman012@mc.duke.edu.
Dr. Gersh can be reached by phone at 507-284-4139; by fax at 507-266-0228; or by email at gersh.bernard@mayo.edu (Please do not publish telephone numbers or email addresses).

For journal copies only, please call: 214-706-1173
For other information, call: Maggie Francis 214-706-1397




American Heart Association

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.